The estimated Net Worth of John J Gormally is at least $6.08 Thousand dollars as of 24 May 2016. John Gormally owns over 2,500 units of Akers Biosciences Inc stock worth over $6,075 and over the last 8 years John sold AKER stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
John Gormally AKER stock SEC Form 4 insiders trading
John has made over 1 trades of the Akers Biosciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently John bought 2,500 units of AKER stock worth $5,575 on 24 May 2016.
The largest trade John's ever made was buying 2,500 units of Akers Biosciences Inc stock on 24 May 2016 worth over $5,575. On average, John trades about 833 units every 0 days since 2016. As of 24 May 2016 John still owns at least 2,500 units of Akers Biosciences Inc stock.
You can see the complete history of John Gormally stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's John Gormally's mailing address?
John's mailing address filed with the SEC is 80 Walsh Dr, Mahwah, NJ 07430, USA.
Insiders trading at Akers Biosciences Inc
Over the last 10 years, insiders at Akers Biosciences Inc have traded over $81,316 worth of Akers Biosciences Inc stock and bought 194,718 units worth $575,645 . The most active insiders traders include Bay Capital Management Lp G..., Billy Joe White, and Joshua Silverman. On average, Akers Biosciences Inc executives and independent directors trade stock every 183 days with the average trade being worth of $52,855. The most recent stock trade was executed by Bay Capital Management Lp G... on 28 February 2020, trading 638 units of AKER stock currently worth $1,793.
What does Akers Biosciences Inc's logo look like?
Complete history of John Gormally stock trades at Akers Biosciences Inc
Akers Biosciences Inc executives and stock owners
Akers Biosciences Inc executives and other stock owners filed with the SEC include:
-
Christopher Schreiber,
President, Chief Executive Officer. Principal Executive Officer -
Stuart Benson,
Chief Financial Officer -
Brett Mass,
Managing Partner -
Robert Schroeder,
Independent Director -
Bill White,
Independent Director -
Joshua Silverman,
Chairman of the Board -
Thomas J Knox,
Director -
Raza Bokhari,
Director -
Gavin Moran,
Director -
Raymond Francis Jr Akers,
Executive Chairman, Secretary -
Brandon Thomas Knox,
Director -
Robert E Andrews,
Director -
John J Gormally,
Chief Executive Officer -
Gary M Rauch,
Controller, Treasurer -
Howard Yeaton,
CEO, CFO -
Bay Capital Management Lp G...,